{"name":"Nevro","slug":"nevro","ticker":"NVRO","exchange":"NYSE","domain":"nevro.com","description":"Nevro is a medical device company that specializes in developing and commercializing innovative solutions for the treatment of chronic pain. The company's flagship product is the Senza system, a spinal cord stimulation (SCS) system that has been shown to be effective in treating chronic back and leg pain. Nevro's products are used in a variety of settings, including hospitals, clinics, and physician offices. The company has a strong presence in the medical device market and is known for its commitment to innovation and customer satisfaction.","hq":"Redwood City, CA","founded":0,"employees":"","ceo":"Kevin Thornal","sector":"Medical Devices","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$540M","metrics":{"revenue":400000000,"revenueGrowth":233.5,"grossMargin":0,"rdSpend":51511000,"netIncome":-113439000,"cash":553841000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2017"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Nevro Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Nevro reported fourth quarter and full year 2023 financial results, with revenue of $233.6 million and $944.6 million, respectively.","drugName":"","sentiment":"neutral"},{"date":"2023-11-15","type":"deal","headline":"Nevro Announces Collaboration with Medtronic to Develop Next-Generation Spinal Cord Stimulation System","summary":"Nevro announced a collaboration with Medtronic to develop a next-generation spinal cord stimulation system.","drugName":"","sentiment":"positive"},{"date":"2023-08-01","type":"regulatory","headline":"Nevro Receives FDA Clearance for Senza System with Advanced Algorithm","summary":"Nevro received FDA clearance for its Senza system with an advanced algorithm, which is designed to improve the accuracy and effectiveness of spinal cord stimulation.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPMUJoSlRMaEN0UUVtekVVTUpBU05wSGtlTjFHX3RVSW1FSlptLTdST2NZT3h2TjRjdzRHSWtIQ1ZqQ2g0SGc5N0dTOFBCazFYdlNZQTlpVFJGSm4tLTBPWnh2X24xOVJ0MnFMNy1tSVI1Y0JaTmdwVVhXSzIwOUp1RlRPVWNFNU51RXhvY0phWnNpOVg4T2N3cEhfMGluLWZGYVJSN3lhVVpBLTVHdEpKMmRfRFgxVmk5Y3FrU3Zn?oc=5","date":"2025-03-04","type":"earnings","source":"PR Newswire","summary":"Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results - PR Newswire","headline":"Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPRk1ONzd2OHVqWTA4Wm9JSDIwc1B5b2s0NFRwWUNac3BrMVFkNWNLd19Ocml5U2JfOHI4T1UyZk4wVDZvSWNQLTdEaE5SemNZMnlJd3QxOFNfRGJLTXg5RjVkN1RUWE9xQ1ItSnB2RzNMaVhaaFdka3JiTWExZ0RDNmVn?oc=5","date":"2025-02-07","type":"deal","source":"Yahoo Finance","summary":"Globus Medical to acquire Nevro for $5.85 per share - Yahoo Finance","headline":"Globus Medical to acquire Nevro for $5.85 per share","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE81dHJWeC13c2xzR2t0YXVxN2ZMcTBFcmNCc1NXSzFWcUNpN0tsblB4YVFmak5QNGxKUE8ybXZlUDk5Z3plWnlydkp6YTViRDAxQWRCLUZLUk1QbjRtRjBGa05WUnNKemNpY2lodWVjUGZFZw?oc=5","date":"2025-02-06","type":"deal","source":"MassDevice","summary":"Globus Medical to acquire Nevro for $250M - MassDevice","headline":"Globus Medical to acquire Nevro for $250M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxQNWUxTFAtcV9WZDBVRFBONWU0N2JXRm5BN21vYlE4VjNwSGdEYVAtOEIxejNUNnlFSFl6QV90UkR0N01JbVBwQUl1S0RUOGUwejdPNEZHYzA5VmdFMTZnZ1RXRnNVNmd3TjNVLTFuU09HYmFsVHlrakJ6Rk1YV0lpbjlKSjBxMkQ0TGV1Vkl0bE1Zd3E2aTdkamd3bWZiTFlWNnpjalAxNmxhVWxJMERfcklBZ3ZJeVlfdXhSYlIwSGZ3S2tleDNRaVBMMkZjTkxvSkJUcmFTZFZ4R29KaHQwZDNxVQ?oc=5","date":"2025-02-06","type":"deal","source":"globenewswire.com","summary":"Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients - globenewswire.com","headline":"Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNZ3owUm5KS1dMeVhhNGJxeW5POVViUjY4LWN5VHhuUGc4VWdnR25QMmtrSERuLTNKa1dORzlRLXBrbkp4UDljM2JTYlJEUEtrbUVucUY4NTRXb2xwd2Jydm5lZVlwX05KWERkdlpDdXZxQ3RrX0VOM2gyYVc0ZVRsR0VBYmhEeUJiMUJKR3p5R0F3a3dGaHFCRV9ic01QZHlFZlBnaEFCbkZrRTNGYlI0Z053MUpjTEMwcUdGU1pzcEgzT2s1c1dlSG0zVnBfYjhaYURseWR4LUhmX0lxUDVmSjc1NzFnQlBxaXJZVw?oc=5","date":"2024-09-24","type":"pipeline","source":"PR Newswire","summary":"Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord Stimulation - PR Newswire","headline":"Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord Stimulation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxQYVp1MVNCZ09zRU0tc2o0bURud3Z4QW1jeXU4eG9Bbmh4U3ZUZlNlTUhXYlFoWFEwUXZtWDBtTm9uMkExSFpLMWdieGdzdzBuekM1MGozMWYybXhzSVp0c1gtWHpaX1hBWTltSm10bmpXWklYWjk1RHdoaTMzODItVGpqVUZjM1E3aGFqelhQUkxlcFN5UG91QkRreGMtVFZVUUFhWlhDamJ4czVTVlRVNVV2Q28tYW5zSVA2ZmpjUDFxRGFPLWZadzVVRHFJT0VETTVSNlFPdnRvU0hFblFXbWE1SGV1WExVY3RPWmtMSXd6QUdGaHJkLS1MbTFzdWJ0eHRPa09VYkJ6c2UyZHFTOWZLeE1nMlpm?oc=5","date":"2023-03-07","type":"pipeline","source":"PR Newswire","summary":"Nevro Announces U.S. Full Market Launch of Revolutionary HFX iQ™ Spinal Cord Stimulation System to Personalize Treatment of Chronic Pain - PR Newswire","headline":"Nevro Announces U.S. Full Market Launch of Revolutionary HFX iQ™ Spinal Cord Stimulation System to Personalize Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQdmYxSFRjVHVvenVFMnhsMTR2U2c4UnRHOWo4azR6V0ludjlBZEN5YW1sRWZKSDMtQkl5VHZEQVNkODUzbWU5dEN6OU1JM3J0S2F3YWVHT2pvWDJBSVc0a2pFOV85dkw4ZHg1TXJNNXdXUHhscFUzM1FZR2hmckVTQXJn?oc=5","date":"2023-01-09","type":"earnings","source":"MassDevice","summary":"Nevro announces CEO succession plan, preliminary Q4 results - MassDevice","headline":"Nevro announces CEO succession plan, preliminary Q4 results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxPaGE2RmtXc1pTaXhtREp0U28zWkVKLXFDbjVEVmVzQ3Vlak05SlZSTGc3a2hhR0dTM3R5QXNoUy1PNjFGU3ZReFdHN2pFeU1hUk9YTVF0bS1DV1VyTl9KdEcxZHIxYlFMdlpQTlJwaHlaYWZDRnZGbHFNWi1VekcxdEJjcG5HWWdGZ3VGUWhrUjJuNU9ZV0twWUQ2WVhTSmVIZU81ZUxwNDRWQ3I1c1NlNVBkVUFxNk8xa0tJcXg5eUNDUmRFcF9IOEI0em03N1Z2TFRiTVdTY2VnamFRUi1UMmhnOENjS0M2ZGlJbXc0UDVLTUZPbWh2aW1QM00wT1U?oc=5","date":"2022-10-12","type":"regulatory","source":"PR Newswire","summary":"Nevro Announces FDA Approval of HFX iQ™ Spinal Cord Stimulation System to Personalize the Treatment of Chronic Pain - PR Newswire","headline":"Nevro Announces FDA Approval of HFX iQ™ Spinal Cord Stimulation System to Personalize the Treatment of Chronic Pain","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxNYTZYNWoxa2IzRW5waHBUVUt4eXJieXdqOEphc3NMb051VnI3Uzk0dkVITEdEZ2o0ZWpWMWUwU2NRV1lSMlhUYlRLZGlSS0xUXzJyTW05VmFVYTZmZjlYRERubVo2RUpISjBOaVZtd1hQYzdhUWxUNTlmclNyWkxWWFIycUZMbGNhbGxwTVFLZEw4MEMtWlBuLUU3a3NxV0J5eV80bGR0YWRIdXV2dmQzc1FIR2I0a3VURnpQSjc3Q05hRHFXUnRUcXNLelRVbGQ5MDJ2WnAwb0JUVWR4d1FRb1Vfa0QtTmg2SmxiSTJMZ1g1Wlh5SFRoNi1IdlBFMXh3TXE1UA?oc=5","date":"2020-02-28","type":"patent","source":"PR Newswire","summary":"Nevro and Stimwave Reach Worldwide Settlement in Patent Infringement Lawsuit: Stimwave Agrees to a Permanent Injunction - PR Newswire","headline":"Nevro and Stimwave Reach Worldwide Settlement in Patent Infringement Lawsuit: Stimwave Agrees to a Permanent Injunction","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Boston Scientific","Medtronic","Abbott Laboratories"],"therapeuticFocus":["Chronic Pain Management","Spinal Cord Stimulation"],"financials":{"source":"sec_edgar","revenue":326674000,"revenuePeriod":"2017-12-31","revenueHistory":[{"value":326674000,"period":"2017-12-31"},{"value":97963000,"period":"2017-12-31"},{"value":82256000,"period":"2017-09-30"},{"value":78016000,"period":"2017-06-30"},{"value":68439000,"period":"2017-03-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":51511000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-113439000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":553841000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}